logo
← ETF screener

Roundhill Investments - GLP-1 & Weight Loss ETF

OZEM

Roundhill Investments

Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) on the Akinda fund screen (AAOIFI-derived): Not halal. Coverage 69.34%. Below: the fund under all five rulebooks, its facts and every holding with its own verdict.

Akinda fund screen

Akinda fund screen (AAOIFI-derived)Not halalCoverage: 69.34%
  • Halal 32.67%
  • Doubtful 0.00%
  • Not halal 36.67%
  • Not rated 30.66%

The bar is scaled to fit; the figures are as reported, and the buckets do not always total 100%.

Coverage is the share of the fund's weight we hold a usable verdict for. Below 95%, a fund is rated only when the weight we can see already breaches the 5% limit; otherwise it is not rated by this method.

Fund facts

Issuer
Roundhill Investments
Venue (where it trades)
United States
Domicile (where it is registered)
United States
Reporting currency
USD
Expense ratio
0.59%
AUM
55.92M USD
Holdings
26 (15 screened)
Basket as of (provider)
26 Oct 2026
Basket fetched by Akinda
26 Oct 2026
Verdict updated
3 Nov 2026

Venue is where a fund trades; domicile is where it is registered. London-listed funds are domiciled in Ireland or Luxembourg, so use Venue for UK ETFs.

Five rulebooks

RulebookVerdictHalalNot halalSplit (0–100%)
Akinda fund screen (AAOIFI)Not halal32.67%36.67%
DJIMNot halal32.67%36.67%
FTSENot halal24.54%44.80%
MSCINot halal24.54%44.80%
S&PNot halal32.67%33.04%

Every bar uses the same 0–100% scale. Index rulebooks report only halal and not-halal weight; uncoloured weight is weight that rulebook does not classify. Coverage is published for the Akinda fund screen only.

The fund screen and the four index rulebooks answer different questions, so they are expected to disagree. A fund can be doubtful on our fund screen and halal under S&P; both are correct.

Holdings

1–26 of 26 holdings, largest first · basket as of 26 Oct 2026
No.HoldingWeightAkinda (AAOIFI)DJIMFTSEMSCIS&P
1
PFEPfizer Inc
8.44%Not halalNot halalHalalHalalNot halal
2
KLRAKailera Therapeutics Inc
6.06%Not halalNot halalNot halalNot halalNot halal
3
1093.HKCSPC Pharmaceutical Group Ltd
5.65%Not ratedNot ratedNot ratedNot ratedNot rated
4
4519.TChugai Pharmaceutical Co Ltd
5.29%Not ratedNot ratedNot ratedNot ratedNot rated
5
AMGNAmgen Inc
4.74%Not halalNot halalNot halalNot halalNot halal
6
VKTXViking Therapeutics Inc
4.26%Not halalNot halalNot halalNot halalNot halal
7
AZNAstraZeneca PLC
4.19%HalalHalalHalalHalalHalal
8
ROP.SWRoche Holding AG
3.68%Not ratedNot ratedNot ratedNot ratedNot rated
9
ZEAL.COZealand Pharma A/S
3.38%Not halalNot halalNot halalNot halalNot rated
10
128940.KSHanmi Pharm Co Ltd
3.34%Not ratedNot ratedNot ratedNot ratedNot rated
11
1672.HKAscletis Pharma Inc
3.09%Not halalNot halalNot halalNot halalNot halal
12
1276.HKJiangsu Hengrui Pharmaceuticals Co Ltd
2.89%Not ratedNot ratedNot ratedNot ratedNot rated
13
3692.HKHansoh Pharmaceutical Group Co Ltd
2.83%Not ratedNot ratedNot ratedNot ratedNot rated
14
3933.HKUnited Laboratories International Holdings Ltd/The
2.59%Not ratedNot ratedNot ratedNot ratedNot rated
15
1801.HKInnovent Biologics Inc
2.19%Not ratedNot ratedNot ratedNot ratedNot rated
16
GUBRA.COGubra A/S
2.15%Not ratedNot ratedNot ratedNot ratedNot rated
17
GILDGilead Sciences Inc
2.01%HalalHalalNot halalNot halalHalal
18
MBXMBX Biosciences Inc
1.80%Not halalNot halalNot halalNot halalNot halal
19
GPCRStructure Therapeutics Inc
1.74%Not halalNot halalNot halalNot halalNot halal
20
4507.TShionogi & Co Ltd
1.47%Not halalNot halalNot halalNot halalNot halal
21
LLYEli Lilly & Co
14.56%HalalHalalNot halalNot halalHalal
22
RYTMRhythm Pharmaceuticals Inc
1.43%Not halalNot halalNot halalNot halalNot halal
23
NVONovo Nordisk A/S
11.91%HalalHalalHalalHalalHalal
24
CHFSWISS FRANC
-0.48%Not ratedNot ratedNot ratedNot ratedNot rated
25
FGXXXFirst American Government Obligations Fund 12/01/2031
0.35%Not ratedNot ratedNot ratedNot ratedNot rated
26
WVEWave Life Sciences Inc
0.26%Not halalNot halalNot halalNot halalNot rated

Not rated means we hold no usable verdict for that company; it is never treated as compliant.

How Akinda screens funds and stocks